发明名称 NITROGEN-CONTAINING CYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
摘要 PROBLEM TO BE SOLVED: To obtain a new compound having excellent calcium antagonism, in particular neuroselective calcium antagonism. SOLUTION: This new compound is represented by the formula [Ar is a (substituted) 5- to 14-membered aromatic cyclic group, or the like; ring A is either one ring selected from piperazine, homopiperazine and piperidine rings, and the like; ring B is a (substituted) 3-14C hydrocarbon ring, or the like; E is a single bond, a group of the formula CO, or the like; X is a single bond, oxygen atom, or the like; R1 is H, a halogen atom, OH, or the like; and D1, D2, W1 and W2 are each a single bond or a (substituted) 1-6C alkylene chain]. This new compound may assume a salt or hydrate form.
申请公布号 JP2001270861(A) 申请公布日期 2001.10.02
申请号 JP20010009591 申请日期 2001.01.18
申请人 EISAI CO LTD 发明人 YAMAMOTO NOBORU;SUZUKI YUICHI;KIMURA MANAMI;NIITOME TETSUHIRO;IIMURA YOICHI;TERAMOTO TETSUYUKI;KANEDA YOSHIHISA;KANEKO TOSHIHIKO;KURUSU NOBUYUKI;SHINMYO DAISUKE;YOSHIKAWA YUKIE;HATAKEYAMA SHINJI
分类号 C07D243/08;A61K31/4025;A61K31/403;A61K31/404;A61K31/438;A61K31/4418;A61K31/4427;A61K31/443;A61K31/4433;A61K31/4439;A61K31/445;A61K31/4468;A61K31/454;A61K31/4545;A61K31/4709;A61K31/495;A61K31/496;A61K31/4995;A61K31/551;A61P3/00;A61P9/00;A61P9/10;A61P25/00;A61P25/06;A61P25/08;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/26;A61P25/28;A61P43/00;C07D207/09;C07D207/337;C07D209/14;C07D209/42;C07D211/22;C07D211/32;C07D211/34;C07D211/46;C07D211/58;C07D213/22;C07D213/36;C07D213/57;C07D215/04;C07D215/12;C07D235/14;C07D235/30;C07D241/04;C07D263/32;C07D263/38;C07D271/06;C07D277/28;C07D277/82;C07D295/14;C07D295/18;C07D307/54;C07D307/81;C07D319/20;C07D333/24;C07D333/60;C07D401/04;C07D401/06;C07D401/12;C07D403/04;C07D405/06;C07D409/06;C07D409/12;C07D409/14;C07D413/12;C07D417/12;C07D471/10;C07D487/08 主分类号 C07D243/08
代理机构 代理人
主权项
地址